COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid
Infección por Achromobacter xylosoxidans en una unidad adulta de fibrosis quística en Madrid
Laura Llorca Oteroa,
Corresponding author
laurallorcaotero@gmail.com

Corresponding author.
, Rosa Girón Morenob, Buenaventura Buendía Morenoa, Claudia Valenzuelab, Alba Guiu Martíneza, Teresa Alarcón Caveroa
a Department of Microbiology, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Diego de León, 62, Madrid, Spain
b Department of Pulmonology, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Diego de León, 62, Madrid, Spain
Read
6519
Times
was read the article
1260
Total PDF
5259
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2015.05.006
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 45 10 55
2024 March 64 1 65
2024 February 61 5 66
2024 January 55 7 62
2023 December 72 6 78
2023 November 56 6 62
2023 October 108 7 115
2023 September 83 5 88
2023 August 35 5 40
2023 July 91 4 95
2023 June 89 6 95
2023 May 113 5 118
2023 April 95 2 97
2023 March 95 28 123
2023 February 58 5 63
2023 January 66 0 66
2022 December 50 13 63
2022 November 78 15 93
2022 October 67 17 84
2022 September 52 13 65
2022 August 55 11 66
2022 July 39 11 50
2022 June 47 14 61
2022 May 44 11 55
2022 April 63 12 75
2022 March 62 12 74
2022 February 58 4 62
2022 January 84 31 115
2021 December 52 16 68
2021 November 57 28 85
2021 October 42 17 59
2021 September 50 16 66
2021 August 51 18 69
2021 July 58 28 86
2021 June 56 28 84
2021 May 49 14 63
2021 April 96 30 126
2021 March 111 14 125
2021 February 64 9 73
2021 January 65 17 82
2020 December 57 14 71
2020 November 69 9 78
2020 October 39 8 47
2020 September 94 28 122
2020 August 94 58 152
2020 July 81 20 101
2020 June 54 17 71
2020 May 81 15 96
2020 April 53 7 60
2020 March 98 17 115
2020 February 71 18 89
2020 January 41 21 62
2019 December 76 25 101
2019 November 46 10 56
2019 October 67 16 83
2019 September 66 13 79
2019 August 39 11 50
2019 July 49 25 74
2019 June 62 24 86
2019 May 195 32 227
2019 April 70 7 77
2019 March 32 8 40
2019 February 37 6 43
2019 January 21 6 27
2018 December 26 7 33
2018 November 31 9 40
2018 October 38 1 39
2018 September 44 6 50
2018 August 10 7 17
2018 July 15 8 23
2018 June 22 5 27
2018 May 20 8 28
2018 April 18 2 20
2018 March 13 4 17
2018 February 8 5 13
2018 January 16 2 18
2017 December 24 1 25
2017 November 16 11 27
2017 October 13 3 16
2017 September 9 5 14
2017 August 15 4 19
2017 July 13 10 23
2017 June 19 9 28
2017 May 22 13 35
2017 April 37 4 41
2017 March 42 26 68
2017 February 22 1 23
2017 January 26 4 30
2016 December 25 6 31
2016 November 35 5 40
2016 October 69 12 81
2016 September 71 10 81
2016 August 44 7 51
2016 July 45 9 54
2016 June 56 34 90
2016 May 42 3 45
2016 April 34 32 66
2016 March 91 71 162
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos